| 摘要 |
Form bodies (F1) comprises at least one member of the antibiotic salts (S1), gentamicin myristate, gentamicin palmitate, gentamicin stearate, tobramycin myristate, tobramycin palmitate, tobramycin stearate, amikacin myristate, amikacin palmitate, amikacin stearate, vancomycin palmitate, vancomycin stearate, ramoplanin palmitate, ramoplanin stearate, levofloxacin palmitate, levofloxacin stearate, ofloxacin palmitate, ofloxacin stearate, moxifloxacin palmitate, moxifloxacin stearate, clindamycin almitate or clindamycin stearate. Independent claims are included for the following: (1) medical device for implantation, comprising form bodies (F1) arranged on a biodegradable filament at a distance of 1-25 mm; and (2) manufacturing a device involving pressing form bodies of at least one antibiotic salt (S1) onto a filament and subsequently heat-treating at 50-70[deg]C. |
